Skip to main content

Insights

Dose of Reality: The Enablement Challenge for Pharmaceutical Dosage Patents
AI generated image
Dose of Reality: The Enablement Challenge for Pharmaceutical Dosage PatentsArticlesFeatured

Dose of Reality: The Enablement Challenge for Pharmaceutical Dosage Patents

A recent decision of the United States Court of Appeals for the Federal Circuit has highlighted the risks of claiming broad pharmaceutical dosage regimens without providing enough practical guidance in the patent specification. In Wyeth LLC v AstraZeneca Pharmaceuticals LP,…
July 30, 2026
Foreign Filing Licences: A Critical Patent Trap for Australian R&D Collaborations with China and India
Foreign Filing Licences: A Critical Patent Trap for Australian R&D Collaborations with China and IndiaArticlesFeatured

Foreign Filing Licences: A Critical Patent Trap for Australian R&D Collaborations with China and India

Australian companies engaged in research and development increasingly collaborate with overseas inventors as part of global R&D programs. China and India, in particular, are key partners for Australian businesses developing advanced technologies in sectors such as mining, energy, medical devices…
June 29, 2026
Maintaining a trade mark registration in the US: A guide for Australian businesses
Maintaining a trade mark registration in the US: A guide for Australian businessesArticlesFeatured

Maintaining a trade mark registration in the US: A guide for Australian businesses

If you own a US trade mark registration, it is important to be aware that you’re required to periodically file proof that you’re still using the mark in the US. If you don’t, your registration will be cancelled. There is…
June 26, 2026
Owning the logo is not owning the words: key lessons from Mobile Skips
Owning the logo is not owning the words: key lessons from Mobile SkipsArticlesFeatured

Owning the logo is not owning the words: key lessons from Mobile Skips

The Federal Court’s decision in Mobile Skips (Australia) Pty Ltd v Registrar of Trade Marks FCA 744 is a timely reminder that a registered logo mark does not necessarily give the owner exclusive rights in the words appearing within that…
June 24, 2026
Pharmaceutical Patent Term Extensions in Australia
Pharmaceutical Patent Term Extensions in AustraliaArticlesFeatured

Pharmaceutical Patent Term Extensions in Australia

Patent term extensions (PTEs) in Australia sit at the centre of a long-running tension between innovation policy and statutory interpretation. Introduced to compensate pharmaceutical patentees for regulatory delay, the regime has increasingly been asked to do more than it was…
June 22, 2026
Australia-European Union Free Trade Agreement and what this means for GI protection in Australia
Australia-European Union Free Trade Agreement and what this means for GI protection in AustraliaArticlesFeaturedFood & Beverage

Australia-European Union Free Trade Agreement and what this means for GI protection in Australia

Australia and the European Union concluded negotiations on a historic free trade agreement on 24 March 2026, following eight years of extensive negotiations. One of the key obstacles to the signing of the Australian and European Union Free Trade Agreement…
June 15, 2026